Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | ADS-5102 | - | - | - | - | [2] 6 6, 13 |
| 2 | ADS-5102 (extended release amantadine HCl) | [1] Amantadine Amantadine | [2] D00777
D00777
,D07441 | [5] GRIN1 GRIN1,GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | [20] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 6 6 |
| 3 | ADS-5102, 137 mg | - | - | - | - | [1] 13 13 |
| 4 | ADS-5102, 274 mg | - | - | - | - | [1] 13 13 |